CRIS : Summary for Curis, Inc. - Yahoo Finance

U.S. Markets closed

Curis, Inc. (CRIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.37-0.04 (-1.66%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close2.41
Bid1.86 x 200
Ask3.99 x 100
Day's Range2.29 - 2.40
52 Week Range1.34 - 3.72
Avg. Volume535,281
Market Cap333.1M
PE Ratio (TTM)-4.92
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire9 days ago

    Curis to Present at the 2017 RBC Capital Markets Global Healthcare Conference

    LEXINGTON, Mass., Feb. 17, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...

  • 3 Top Stocks Under $5
    Motley Foollast month

    3 Top Stocks Under $5

    Cheap stocks are often cheap for a reason, but sometimes the market has mispriced their potential.

  • Curis, Inc. – Value Analysis (NASDAQ:CRIS) : January 13, 2017
    Capital Cubelast month

    Curis, Inc. – Value Analysis (NASDAQ:CRIS) : January 13, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Curis, Inc. a score of 25. Our analysis is based on comparing Curis, Inc. with the following peers – Exelixis, Inc., Infinity Pharmaceuticals, Inc., Emergent BioSolutions Inc., Bristol-Myers Squibb Company, Spectrum Pharmaceuticals, Inc., Tetralogic Pharmaceuticals Corporation, Celldex Therapeutics, Inc., Pfizer Inc., Celgene Corporation and Madrigal Pharmaceuticals, Inc. ... Read more (Read more...)